AC
BSX icon

Alexandria Capital’s Boston Scientific BSX Stock Holding History

Alexandria Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-238
Closed -$7K – 271
2017
Q3 		$7K Buy
238
+37
+18% +$1.02K ﹤0.01% 434
2017
Q2 		$6K Buy
201
+34
+20% +$902 ﹤0.01% 464
2017
Q1 		$4K Buy
+167
New +$4.06K ﹤0.01% 497

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Alexandria Capital's BSX Position: Q4 2017 in Review

Alexandria Capital sold out of Boston Scientific (BSX) in Q4 2017, closing a stake of 238 shares — an estimated $7K sold.

Alexandria Capital first reported a position in BSX in Q1 2017 and held it in 3 quarters. The position peaked at $7K in Q3 2017. 632 funds tracked by Wall St. Rank hold BSX as of Q4 2017.

  • Alexandria Capital reported no remaining Boston Scientific position as of Q4 2017 after selling out during the quarter.
  • Alexandria Capital sold 238 Boston Scientific shares in Q4 2017, an estimated $7K.
  • Alexandria Capital first reported a position in Boston Scientific in Q1 2017 and held it in 3 quarters.
  • Alexandria Capital's Boston Scientific position peaked at $7K in Q3 2017.
  • 632 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2017.

Based on Alexandria Capital's 13F filing for Q4 2017, filed 9 Feb 2018.